신생아 폐질환 발생과 연관된 한국인의 후보유전자

키워드

참고문헌 (46)

1. Sung-Hoon Chung, "Changes in the neonatal and infant mortality rate and the causes of death in Korea", Korean Journal of Pediatrics, 54(11), pp.443~455 (2011), 대한소아과학회
2. 배종우, "Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years", Journal of Korean Medical Science, 24(6), pp.1110~1118 (2009), 대한의학회
3. 김소영, "Neonatal respiratory distress: recent progress in understanding pathogenesis and treatment outcomes", Korean Journal of Pediatrics, 53(1), pp.1~6 (2010), 대한소아과학회
4. 김병일, "새로운 유형의 기관지폐이형성증의 임상적 특성, 역학, 병리기전에 대한 국내외 최근 연구동향", Korean Journal of Pediatrics, 52(1), pp.6~13 (2009), 대한소아과학회
5. Hayes D Jr, "Pathogenesis of bronchopulmonary dysplasia", Respiration, 79, pp.425~436 (2010)
6. Hallman M, "Genes and environment in common neonatal lung disease", Neonatology, 91, pp.298~302 (2007)
7. Marttila R, "Surfactant protein B polymorphism and respiratory distress syndrome in premature twins", Hum Genet, 112, pp.18~23 (2003)
8. van Sonderen L, "Genetic influences in respiratory distress syndrome: a twin study", Semin Perinatol, 26, pp.447~449 (2002)
9. Bhandari V, "Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins", Pediatrics, 117, pp.1901~1906 (2006)
10. Parker RA, "Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia", Semin Perinatol, 20, pp.206~209 (1996)
11. Hamvas A, "Pathophysiology and treatment of surfactant protein-B deficiency", Biol Neonate, 67, pp.18~31 (1995)
12. Whitsett JA, "Genetic disorders influencing lung formation and function at birth", Hum Mol Genet, 13, pp.R207~R215 (2004)
13. Silveyra P, "Genetic variant associations of human SPA and SP-D with acute and chronic lung injury", Front Biosci (Landmark Ed), 17, pp.407~429 (2012)
14. Wang G, "Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1and SP-A2: formation of tubular myelin in vivo requires both gene products", J Biol Chem, 285, pp.11998~12010 (2010)
15. Rämet M, "Association between the surfactant protein A (SP-A) gene locus and respiratory distress syndrome in the Finnish population", Am J Hum Genet, 66, pp.1569~1579 (2000)
16. Haataja R, "Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome", Hum Mol Genet, 9, pp.2751~2760 (2000)
17. Floros J, "Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences", Clin Genet, 60, pp.178~187 (2001)
18. Jo HS, "Surfactant protein A associated with respiratory distress syndrome in Korean preterm infants: evidence of ethnic difference", Neonatology, 103, pp.44~47 (2013)
19. Thomas NJ, "Haplotypes of the surfactant protein genes A and D as susceptibility factors for the development of respiratory distress syndrome", Acta Paediatr, 96, pp.985~989 (2007)
20. Marttila R, "Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins", Am J Respir Crit Care Med, 168, pp.1216~1222 (2003)
21. Lahti M, "Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease", Eur J Hum Genet, 12, pp.312~320 (2004)
22. Leth-Larsen R, "A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D", J Immunol, 174, pp.1532~1538 (2005)
23. Hilgendorff A, "Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant", Acta Paediatr, 98, pp.112~117 (2009)
24. Karjalainen MK, "Haplotype analysis of ABCA3: association with respiratory distress in very premature infants", Ann Med, 40, pp.56~65 (2008)
25. Pulkkinen V, "G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndrome", Ann Med, 38, pp.357~366 (2006)
26. Bokodi G, "Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA", GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates, 2007, pp.92, F25~F29
27. 박은애, "한국 미숙아 산모와 제대혈의 IL-10 유전자형 빈도와 신생아 호흡 곤란증 발생과의 연관성", Neonatal medicine, 16(2), pp.137~145 (2009), 대한신생아학회
28. Shaw GM, "Progress in understanding the genetics of bronchopulmonary dysplasia", Semin Perinatol, 37, pp.85~93 (2013)
29. Bhandari V, "The genetics of bronchopulmonary dysplasia", Semin Perinatol, 30, pp.185~191 (2006)
30. Floros J, "IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants", Pediatr Res, 71, pp.107~114 (2012)
31. Adcock K, "The TNFalpha -308, MCP-1-2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants", Genes Immun, 4, pp.420~426 (2003)
32. Kazzi SN, "Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants", Pediatrics, 114, pp.e243~e248 (2004)
33. Chauhan M, "Tumour necrosis factor (--308A) polymorphism in very preterm infants with bronchopulmonary dysplasia: a meta-analysis", Arch Dis Child Fetal Neonatal Ed, 94, pp.F257~F259 (2009)
34. 조희승, "조산아 기관지폐이형성증과 Tumor Necrosis Factor-α 유전자 다 형성과의 연관성", Neonatal medicine, 18(1), pp.42~48 (2011), 대한신생아학회
35. Baier RJ, "CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia", Pediatr Pulmonol, 37, pp.137~148 (2004)
36. Turner DM, "An investigation of polymorphism in the interleukin- 10 gene promoter", Eur J Immunogenet, 24, pp.1~8 (1997)
37. Yanamandra K, "Interleukin-10 -1082 G", A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants, 2005, pp.39, 426~432
38. Lin HC, "Nonassociation of interleukin 4 intron 3 and 590 promoter polymorphisms with bronchopulmonary dysplasia for ventilated preterm infants", Biol Neonate, 87, pp.181~186 (2005)
39. Yanamandra K, "The Angiotensin Converting Enzyme Insertion", Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants, 2004, pp.4, 26~
40. Kazzi SN, "Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia", J Pediatr, 147, pp.818~822 (2005)
41. Ryckman KK, "Genetic associations of surfactant protein D and angiotensinconverting enzyme with lung disease in preterm neonates", J Perinatol, 32, pp.349~355 (2012)
42. Manar MH, "Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia", J Perinatol, 24, pp.30~35 (2004)
43. Chetty A, "Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD", Pediatr Pulmonol, 37, pp.128~136 (2004)
44. Balogh A, "A prevalent functional polymorphism of insulin-like growth factor system is not associated with perinatal complications in preterm infants", Pediatrics, 117, pp.591~592 (2006)
45. Weber B, "Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants", Turk J Pediatr, 42, pp.181~185 (2000)
46. Rova M, "Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia", Hum Mol Genet, 13, pp.1095~1104 (2004)

관련 논문AI추천